Cargando…

The pancreas in human type 1 diabetes

Type 1 diabetes (T1D) is considered a disorder whose pathogenesis is autoimmune in origin, a notion drawn in large part from studies of human pancreata performed as far back as the 1960s. While studies of the genetics, epidemiology, and peripheral immunity in T1D have been subject to widespread anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowe, Patrick A., Campbell-Thompson, Martha L., Schatz, Desmond A., Atkinson, Mark A.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022158/ https://www.ncbi.nlm.nih.gov/pubmed/20495921 http://dx.doi.org/10.1007/s00281-010-0208-x

Ejemplares similares

Increased Complement Activation in Human Type 1 Diabetes Pancreata
por: Rowe, Patrick, et al.
Publicado: (2013)

Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies
por: Bruggeman, Brittany S., et al.
Publicado: (2021)

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2016)

It's Time to Mow the GRAS in Type 1 Diabetes
por: Schatz, Desmond A., et al.
Publicado: (2011)

339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes.
por: Bruggeman, Brittany S, et al.
Publicado: (2022)

Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes
por: Burch, Tanya C., et al.
Publicado: (2015)

Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017)

Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
por: Xue, Song, et al.
Publicado: (2015)

Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2021)

Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
por: Butler, Alexandra E., et al.
Publicado: (2013)

Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method
por: Tao, Betty, et al.
Publicado: (2010)

The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings
por: Pugliese, Alberto, et al.
Publicado: (2014)

Reponse to Comments on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595–2604
por: Butler, Alexandra E., et al.
Publicado: (2013)

Mast Cells and the Pancreas in Human Type 1 and Type 2 Diabetes
por: Masini, Matilde, et al.
Publicado: (2021)

New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation
por: Pugliese, Alberto, et al.
Publicado: (2014)

Islet amyloidosis in a child with type 1 diabetes
por: Beery, Maria L., et al.
Publicado: (2019)

Pancreas Optical Clearing and 3-D Microscopy in Health and Diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2021)

Vitamin D Levels in Subjects With and Without Type 1 Diabetes Residing in a Solar Rich Environment
por: Bierschenk, Lindsey, et al.
Publicado: (2009)

Improving the Prediction of Type 1 Diabetes Across Ancestries
por: Kaddis, John S., et al.
Publicado: (2022)

Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice
por: Posgai, Amanda L., et al.
Publicado: (2017)

Large-scale electron microscopy database for human type 1 diabetes
por: de Boer, Pascal, et al.
Publicado: (2020)

Understanding Pre-Type 1 Diabetes: The Key to Prevention
por: Jacobsen, Laura M., et al.
Publicado: (2018)

Coming of age: the artificial pancreas for type 1 diabetes
por: Thabit, Hood, et al.
Publicado: (2016)

Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes
por: Mathews, Clayton E., et al.
Publicado: (2015)

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network
por: Butterworth, Elizabeth, et al.
Publicado: (2018)

Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population
por: Simell, Olli, et al.
Publicado: (2010)

Human immune phenotyping reveals accelerated aging in type 1 diabetes
por: Shapiro, Melanie R., et al.
Publicado: (2023)

A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice
por: Yoon, Young Mee, et al.
Publicado: (2015)

Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry
por: Wu, Minghui, et al.
Publicado: (2021)

Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes
por: Esposito, Susanna, et al.
Publicado: (2018)

Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes
por: Kattner, Nicole
Publicado: (2023)

Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes
por: Ize-Ludlow, Diego, et al.
Publicado: (2011)

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes
por: Haller, Michael J., et al.
Publicado: (2009)

Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice
por: Parker, Matthew J., et al.
Publicado: (2009)

Disease progression joint model predicts time to type 1 diabetes onset: Optimizing future type 1 diabetes prevention studies
por: Morales, Juan Francisco, et al.
Publicado: (2023)

Disparities in Social Support Systems for Youths With Type 1 Diabetes
por: Walker, Ashby F., et al.
Publicado: (2015)

Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas
por: Jean-Baptiste, Virginie S.E., et al.
Publicado: (2017)

Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012)

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial
por: Vehik, Kendra, et al.
Publicado: (2011)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j3sph10eoqchmcm5dd9v03k3or